Neuralink, the brain-computer interface company founded by Elon Musk, is seeking to raise an ambitious $500 million in fresh funding. The company, still in the early stages of clinical trials, is targeting a pre-money valuation of $8.5 billion—a significant jump from last year’s $5 billion. If the round succeeds, Neuralink’s total valuation would soar to roughly $9 billion. This pursuit of capital comes despite ongoing ethical, scientific, and regulatory hurdles, as well as growing scrutiny from oversight bodies.
The company gained global attention earlier this year when its brain implant allowed a paralyzed man to operate a computer cursor and surf the web using only his thoughts. Though hailed as a breakthrough, complications quickly emerged—some of the implant’s electrode threads began retracting, potentially affecting performance. Such issues echo past challenges; in 2023, the U.S. FDA initially blocked human testing over safety concerns, though it later granted approval. However, the SEC has since reopened an investigation into whether Neuralink exaggerated the chip’s capabilities.
Despite these setbacks, Neuralink remains one of the most visible players in the neurotech space, thanks largely to Musk’s high-profile persona and bold promises. While rivals like Synchron and Precision Neuroscience are gaining momentum—with the latter securing a “Breakthrough Device” designation from the FDA—Neuralink garners outsized attention. Musk has publicly suggested the chip could one day help treat conditions such as depression, autism, and schizophrenia, and even enable telepathic communication.
The company is still actively recruiting participants for its PRIME Study, which targets individuals with severe spinal cord injuries or ALS to test the chip’s real-world applications. As Neuralink eyes its next big funding round, the pressure is on to convert its visionary potential into dependable outcomes. Unlike Musk’s other ventures—Tesla, SpaceX, or xAI—Neuralink deals directly with human cognition and trust, adding a deeper layer of complexity to both its mission and its promises.